Effect of Dried Fruit on Cardiometabolic Risk Factors

August 15, 2023 updated by: Penn State University

The Effect of Bioactives in Dried Plums, Figs, Dates, and Raisins Compared With a High Carbohydrate Snack on Risk Factors for Cardiometabolic Disease

This is a 2-period randomized crossover study with free-living subjects on self-selected diets. The objective of this study is to compare the effects of ¾ cup of a blend of dried plums, figs, dates and raisins (DPFDR) with an isocaloric and macronutrient matched snack food on blood pressure, vascular health and lipids and lipoproteins in 50 participants who are representative of the U.S. population and at risk for cardiovascular disease (overweight/obese, elevated LDL-cholesterol, prehypertension, and/or prediabetes).

The investigators hypothesize that the inclusion of DPFDR in the diet will decrease blood pressure and LDL-cholesterol, and improve artery function (assessed by standard blood pressure measure, 24 hr ambulatory blood pressure, central blood pressure and arterial stiffness) compared to the control group and baseline.

Study Overview

Study Type

Interventional

Enrollment (Actual)

55

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pennsylvania
      • University Park, Pennsylvania, United States, 16802
        • Penn State University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Body mass index of 25-36 kg/m2

And, at least one of the following:

  • LDL-C above 116 mg/dL (3.0 mmol/L)
  • Systolic blood pressure 120-159 mmHg
  • Diastolic blood pressure 80-99 mmHg
  • Increased waist circumference: ≥94 cm for men and ≥80 cm for women
  • Elevated glucose (≥ 100 mg/dL and < 126 mg/dL)
  • Triglycerides: above 150 mg/dL (1.69 mmol/L) and below 350 mg/dL (3.95 mmol/L)
  • Low HDL-cholesterol: <40 mg/dL (< 1.03 mmol/L) for men and < 50 mg/dL (<1.29 mmol/L) for women)

Exclusion Criteria:

  • Allergies to the test foods
  • History of cardiovascular disease, stage II hypertension (BP 160/100 mmHg), kidney disease, diabetes or inflammatory diseases such as gastrointestinal disorders and rheumatoid arthritis
  • Use of medication/supplements for elevated lipids, blood pressure, or glucose

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dried Fruit
Daily consumption of ¾ cup blend of dried plums, figs, dates and raisins (DPFDR) for 4 weeks
Mixture of equal parts 4 dried fruits (figs, raisins, dates, plums) totaling 3/4 cup daily.
Experimental: Control
Daily consumption of isocaloric and macronutrient matched snack food for 4 weeks
Calorie-matched carbohydrate-rich snack.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
LDL Cholesterol
Time Frame: 4 weeks
serum low-density cholesterol concentration
4 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
HDL-cholesterol, non-HDL cholesterol, triglycerides
Time Frame: 4 weeks
serum concentrations of HDL and non-HDL cholesterol and triglycerides
4 weeks
Central blood pressure
Time Frame: 4 weeks
central systolic and diastolic blood pressure
4 weeks
Pulse wave velocity
Time Frame: 4 weeks
carotid-femoral pulse wave velocity
4 weeks
Brachial blood pressure
Time Frame: 4 weeks
brachial systolic and diastolic blood pressure
4 weeks
Plasma glucose
Time Frame: 4 weeks
fasting plasma glucose
4 weeks
High-sensitivity C-reactive protein
Time Frame: 4 weeks
serum hs-CRP
4 weeks
Serum insulin
Time Frame: 4 weeks
fasting serum insulin
4 weeks

Other Outcome Measures

Outcome Measure
Time Frame
Fecal Microbiome
Time Frame: 4 weeks
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Penny Kris-Etherton, PhD, Penn State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2017

Primary Completion (Actual)

November 30, 2018

Study Completion (Actual)

November 30, 2018

Study Registration Dates

First Submitted

January 3, 2017

First Submitted That Met QC Criteria

January 12, 2017

First Posted (Estimated)

January 13, 2017

Study Record Updates

Last Update Posted (Actual)

August 18, 2023

Last Update Submitted That Met QC Criteria

August 15, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on Dried Fruit

Subscribe